Chemicalexchange.Com (Bombay) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-07-2024
- Paid Up Capital ₹ 0.10 M
as on 09-07-2024
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -8.02%
(FY 2022)
- Profit -34.10%
(FY 2022)
- Ebitda -14.29%
(FY 2022)
- Net Worth 9.39%
(FY 2022)
- Total Assets 3.28%
(FY 2022)
About Chemicalexchange.Com (Bombay)
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Komal Agarwal and Suman Agarwal serve as directors at the Company.
- CIN/LLPIN
U30005MH1999PTC117939
- Company No.
117939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chemicalexchange.Com (Bombay)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suman Agarwal  | Director | 01-Nov-2007 | Current |
| Komal Agarwal | Additional Director | 06-Dec-2018 | Current |
Financial Performance of Chemicalexchange.Com (Bombay).
Chemicalexchange.Com (Bombay) Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.02% decrease. The company also saw a substantial fall in profitability, with a 34.1% decrease in profit. The company's net worth moved up by a moderate rise of 9.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemicalexchange.Com (Bombay)?
In 2021, Chemicalexchange.Com (Bombay) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Selfcare Support Private LimitedActive 11 years 25 daysKomal Agarwal and Suman Agarwal are mutual person
Aadesh Brine Private LimitedActive 11 years 11 monthsKomal Agarwal and Suman Agarwal are mutual person
- Sumex Petrochem Private LimitedActive 5 years 11 months
Komal Agarwal and Suman Agarwal are mutual person
- Jampask Estate Private LimitedActive 6 months 11 days
Komal Agarwal and Suman Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemicalexchange.Com (Bombay)?
Unlock and access historical data on people associated with Chemicalexchange.Com (Bombay), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemicalexchange.Com (Bombay), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemicalexchange.Com (Bombay)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
